Related Experiment Video
Updated: Mar 18, 2026

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
The gut microbiota and inflammatory bowel diseases
1Department of Medicine, The University of Chicago, Chicago, Ill.
Inflammatory bowel diseases (IBD) involve complex interactions between genetics, environment, and gut microbes, causing intestinal inflammation. Further research is needed to understand these factors for better IBD treatments.
Area of Science:
- Gastroenterology and Immunology
- Microbiome Research
Background:
- Inflammatory bowel diseases (IBD) are chronic, global conditions affecting millions, characterized by intestinal inflammation.
- IBD etiology is multifactorial, involving genetic, environmental, and microbial factors triggering immune responses.
- The global prevalence of IBD is increasing, particularly in industrialized nations across continents.
Purpose of the Study:
- To elucidate the complex interplay of genetic, environmental, and microbial factors in IBD pathogenesis.
- To address challenges in understanding functional consequences of gut dysbiosis and host-microbiota interactions in IBD.
- To highlight the need for advanced methodologies and improved clinical study designs for IBD research.
Main Methods:
- Utilizing advances in cultivation-independent investigations for microbial analysis.
- Employing experimental models to study host-microbiota interactions.
- Leveraging bioinformatics approaches to analyze complex biological data.
Main Results:
- Improved understanding of the gut microbiota's role in IBD through modern research techniques.
- Identification of challenges in establishing causality due to limitations in experimental models and human studies.
- Recognition of the need for continued methodological development in IBD research.
Conclusions:
- Understanding the gut microbiota's role is crucial for IBD pathogenesis.
- Current experimental and human-based investigation methods have limitations in determining causal links.
- Advancing research methodologies and clinical study designs is essential for improving IBD therapeutic strategies and patient outcomes.
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Functions of the Gut Microbiota
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Gut-Brain Axis

